Literature DB >> 18185948

Serum markers of systemic right ventricular function and exercise performance.

Ruchira Garg1, Subha V Raman, Timothy M Hoffman, John Hayes, Curt J Daniels.   

Abstract

The right ventricle, which faces systemic pressure due to congenital heart disease, often develops premature systolic dysfunction. Cardiac hormones might be useful to identify patients with such systolic dysfunction. This prospective study investigated the relationship of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) levels with right ventricular ejection fraction (RVEF) and exercise performance in patients with a systemic right ventricle. ANP levels were obtained in 24 patients and BNP levels were obtained in 22 patients with systemic right ventricle. Patients underwent exercise study (n = 22) and cardiovascular magnetic resonance imaging (n = 11) or equilibrium radionuclide angiography (n = 13) to determine RVEF. There were 17 patients with complete transposition and 7 patients with corrected transposition. ANP showed an inverse correlation with RVEF (r2 = 0.63, p < 0.001), a weak but statistically significant inverse correlation with exercise duration (r2 = 0.18, p = 0.047) and no relationship with maximal oxygen consumption (peak V'O2) (r2 = 0.10, p = NS). BNP did not show a relationship with any of the parameters measured. ANP shows a strong inverse correlation with RVEF and a weak correlation with exercise duration in patients with a systemic right ventricle. BNP does not show a significant relationship when compared with either parameter. ANP might be a useful tool for identification of systolic right ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185948     DOI: 10.1007/s00246-007-9187-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  40 in total

1.  Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients.

Authors:  Hideo Ohuchi; Hisashi Takasugi; Hiroyuki Ohashi; Osamu Yamada; Ken Watanabe; Toshikatsu Yagihara; Shigeyuki Echigo
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

Review 2.  Assessment of the right ventricle with radionuclide techniques.

Authors:  D S Schulman
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 3.  B-type natriuretic peptide in the diagnosis and management of congestive heart failure.

Authors:  A Maisel
Journal:  Cardiol Clin       Date:  2001-11       Impact factor: 2.213

4.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.

Authors:  Emily Lubien; Anthony DeMaria; Padma Krishnaswamy; Paul Clopton; Jen Koon; Radmila Kazanegra; Nancy Gardetto; Erin Wanner; Alan S Maisel
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

5.  Reproducibility of MRI-derived measurements of right ventricular volumes and myocardial mass.

Authors:  P M Pattynama; H J Lamb; E A Van der Velde; R J Van der Geest; E E Van der Wall; A De Roos
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

Review 6.  Natriuretic peptides in assessment of left-ventricular dysfunction.

Authors:  J Mair; W Friedl; S Thomas; B Puschendorf
Journal:  Scand J Clin Lab Invest Suppl       Date:  1999

7.  A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.

Authors:  Stacey J Wieczorek; Alan H B Wu; Robert Christenson; Padma Krishnaswamy; Stephen Gottlieb; Thomas Rosano; David Hager; Nancy Gardetto; Albert Chiu; Kathryn R Bailly; Alan Maisel
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

8.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

9.  Tricuspid atresia with transposition of the great arteries in adolescents and adults: current state and late complications.

Authors:  C A Warnes; J Somerville
Journal:  Br Heart J       Date:  1987-06

10.  Tricuspid atresia in adolescents and adults: current state and late complications.

Authors:  C A Warnes; J Somerville
Journal:  Br Heart J       Date:  1986-12
View more
  5 in total

Review 1.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

2.  Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.

Authors:  Kenji Miyamoto; Daiji Takeuchi; Kei Inai; Tokuko Shinohara; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-02-08       Impact factor: 2.037

Review 3.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

4.  Angiopoietin-2 in adults with congenital heart disease and heart failure.

Authors:  Alexander Lukasz; Gernot Beutel; Philipp Kümpers; Agnieszka Denecke; Mechthild Westhoff-Bleck; Bernhard Schieffer; Johann Bauersachs; Jan T Kielstein; Oktay Tutarel
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.

Authors:  Oktay Tutarel; Agnieszka Denecke; Stefanie M Bode-Böger; Jens Martens-Lobenhoffer; Svjetlana Lovric; Johann Bauersachs; Bernhard Schieffer; Mechthild Westhoff-Bleck; Jan T Kielstein
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.